Closed · RFA-CK-22-004 · CFDA 93.084 · Discretionary

Optimization and Standardization of Methods to Suppress Ixodes scapularis and Disrupt Enzootic Pathogen Transmission in Settings Posing an Elevated Risk to Humans

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

$750K-$1M
Award range
Closed
Status
February 15, 2022
Close date
1
Expected awards

The verdict

Optimization and Standardization of Methods to Suppress Ixodes scapularis and Disrupt Enzootic Pathogen Transmission in Settings Posing an Elevated Risk to Humans is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $750,000 -- $1,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number.

$750K-$1M
award range
Closed
application status
1
expected award
93.084
CFDA program

Opportunity snapshot. This Grants.gov announcement - Optimization and Standardization of Methods to Suppress Ixodes scapularis and Disrupt Enzootic Pathogen Transmission in Settings Posing an Elevated Risk to Humans - is cataloged under number RFA-CK-22-004 and tied to CFDA assistance listing 93.084, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on December 14, 2021 and last updated on January 13, 2022. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is $750,000 -- $1,000,000. The agency has projected $5.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $5.0 million estimated pool, the average award works out to roughly $5.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on February 15, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

$750,000 -- $1,000,000

Close Date

February 15, 2022

Electronically submitted applications must be submitted no later than 5:00 pm ET on the listed application due date.

Posted

December 14, 2021

Est. Total Funding

$5,000,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

This NOFO intends to support research to: 1) optimize and standardize implementation of existing strategies to reduce the abundance of host-seeking Ixodes scapularis nymphs infected with human pathogens, especially Lyme disease spirochetes (DIN); 2) evaluate efficacy and reproducibility of operational use (e.g., in the hands of pest control professionals or the public, as appropriate) of these protocols in high-risk settings (e.g., wooded residential properties, high-use wooded recreational areas) across the Midwest, Northeast and Mid-Atlantic United States where baseline DIN is elevated; and 3) develop standard operating procedures that may be used by homeowners or vector control professionals to implement these interventions within communities at risk for exposure to Lyme disease spirochetes and other I. scapularis-borne pathogens.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Amy Yang AYang@cdc.gov

Key Dates

Posted December 14, 2021
Close Date February 15, 2022
Archive Date March 15, 2022
Last Updated January 13, 2022

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Optimization and Standardization of Methods to Suppress Ixodes scapularis and Disrupt Enzootic Pathogen Transmission in Settings Posing an Elevated Risk to Humans", offered by Centers for Disease Control and Prevention - ERA. It is associated with CFDA program 93.084. This NOFO intends to support research to: 1) optimize and standardize implementation of existing strategies to reduce the abundance of host-seeking Ixodes scapularis nymphs infected with human pathoge...
Is this opportunity still open?
No, this opportunity is closed. It closed on February 15, 2022. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is $750,000 -- $1,000,000. Total estimated funding: $5,000,000. Expected number of awards: 1.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants